How does elinzanetant work?
It blocks brain chemicals responsible for hot flashes and night sweats.
Yanuki
ARTICLE DETAIL
FDA Approves New Hormone-Free Menopause Drug | Emotional Marathon Training and Boston Marathon Jacket Redesign | Why Are More Young Adults Having Strokes? Donald Glover's Health Scare | FDA Approves New Hormone-Free Menopause Drug | Emotional Marathon Training and Boston Marathon Jacket Redesign | Why Are More Young Adults Having Strokes? Donald Glover's Health Scare
Health & Fitness / Health
FDA Approves New Hormone-Free Menopause Drug
The FDA has approved a new hormone-free drug, elinzanetant (brand name Lynkuet), developed by Bayer, to alleviate moderate to severe hot flashes in menopausal women. This offers a new option for those who cannot or prefer not to use hormone...
Key Insights
- The FDA approved elinzanetant (Lynkuet) as a once-a-day, hormone-free pill for hot flashes.
- It works by blocking brain chemicals that cause hot flashes and night sweats (vasomotor symptoms).
- Clinical trials showed a 73% reduction in vasomotor symptoms compared to a 47% reduction with a placebo.
- Common side effects include drowsiness, fatigue, and headaches.
- This matters because it provides an alternative for women who can’t or don’t want to use hormone therapy, addressing a significant gap in treatment options.
In-Depth Analysis
The drug, elinzanetant, represents a significant advancement in menopause treatment. Unlike hormone replacement therapies, it targets the neurokinin pathway in the brain, which is responsible for triggering hot flashes when estrogen levels decline during menopause. A Phase 3 clinical trial involving 628 postmenopausal women demonstrated that elinzanetant significantly reduced the frequency and severity of vasomotor symptoms. This new option expands the range of treatments available, allowing for more individualized approaches to menopause care. This drug is expected to be available in the United States beginning in November.
FAQ
What are the common side effects?
Drowsiness, fatigue, and headaches.
When will Lynkuet be available?
Expected to be available in the United States beginning in November.
Takeaways
- If you experience moderate to severe hot flashes during menopause, elinzanetant (Lynkuet) offers a hormone-free treatment option.
- Consult your healthcare provider to determine if this drug is suitable for you, especially if hormone therapy is not an option.
- The drug has been shown to significantly reduce the frequency and severity of hot flashes, improving daily life quality.
Discussion
Do you think this new treatment option will significantly improve the quality of life for women experiencing menopause? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.